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Pain is a major symptom in cancer patients, and most cancer
patients with advanced or terminal cancers suffer from chronic
pain related to treatment failure and/or tumor progression. In
the present study, we examined the development of cancer
pain in mice. Murine hepatocarcinoma cells, HCa-1, were
inoculated unilaterally into the thigh or the dorsum of the foot
of male C3H/HeJ mice. Four weeks after inoculation,
behavioral signs were observed for mechanical allodynia, cold
allodynia, and hyperalgesia using a von Frey filament, acetone,
and radiant heat, respectively. Bone invasion by the tumor
commenced from 7 days after inoculation of tumor cells and
was evident from 14 days after inoculation. Cold allodynia but
neither mechanical allodynia nor hyperalgesia was observed in
mice that received an inoculation into the thigh. On the
contrary, mechanical allodynia and cold allodynia, but not
hyperalgesia, were developed in mice with an inoculation into
the foot. Sometimes, mirror-image pain was developed in these
animals. These results suggest that carcinoma cells injected
into the foot of mice may develop severe chronic pain related
to cancer. This animal model of pain would be useful to
elucidate the mechanisms of cancer pain in humans.
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INTRODUCTION
Chronic pain is a major symptom in cancer
patients with advanced or terminal cancers. These
patients suffer from chronic pain related to
treatment failure and/or tumor progression.
Cancer pain might be related to invasion of either
peripheral nerves or bones, which accounts for
75% of all chronic cancer pain.
1
Clinical literature regarding cancer pain assess-
ment and management is extensive. However,
the understanding of the mechanisms that under-
lie the production of pain associated with
malignancy is meager at best. An understanding
of these basic mechanisms is essential for the
development of better therapeutic approaches to
cancer pain treatment, but efforts to gain such in-
formation are hampered by the lack of adequate
animal tumor models. While investigations have
been accumulated on neuropathic pain using ani-
mal models,
2-4 cancer pain by bone invasion
hasn't been extensively studied. Recently, Schwei
et al.
5 described a femur model of bone cancer
pain that allowed characterization of neuro-
chemical changes in the spinal cord associated
with development of tumor-induced nociception.
Similarly, Medhurst et al.
6 reported that rats
receiving intra-tibial injections of MRMT-1 cells
displayed the gradual development of mechani-
cal allodynia and mechanical hyperalgesia and
reduced weight bearing on the affected limb.
Although the femur or tibial bone tumor
model provides a valuable archetype to assess
CNS changes, it is difficult to examine the func-
tion of the hind paw which has been studied
widely. This study was conducted to develop a
new mouse model of cancer pain by comparing
cancer pain-related behaviors produced by tu-
mors located in different sites of the hind limbs
of mice.
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MATERIALS AND METHODS
Subjects
A total of 105 male C3H/HeJ mice (8-10 weeks
old, 22-26 g) were used. Mice were bred and
maintained at five animals per cage. The tem-
perature and humidity were constantly controlled.
Water and diet were supplied ad libitum. Ex-
periments were carried out in accordance with the
guidelines laid down by the NIH in the US re-
garding the care and use of animals for ex-
perimental procedures. All procedures were ap-
proved by the Committee for Animal Experiments
in Yonsei University College of Medicine.
Inoculation of carcinoma cells
A murine hepatocarcinoma syngeneic to C3H/
HeJ, murine hepatocarcinoma (HCa-1), was used
in the present study. Suspensions of 10
6 tumor
cells were prepared following Milas et al.
7 Cells
were injected unilaterally into the thigh or the
dorsum of the foot of male C3H/HeJ mice. Mice
were regularly sacrificed and bone invasion by
the tumor was histologically examined.
Behavioral tests for cancer pain
Behavioral signs of different components of
cancer pain were observed in all of the mice
before the inoculation and then on days 1, 3, 5,
7, 14, 21, and 28 after inoculation. The behavioral
testing procedures followed those reported by
Lee et al.
8 with some modifications. To measure
mechanical allodynia, mice were placed on a
metal mesh floor under a transparent plastic
dome (8×5×4.5 cm), and allowed to habituate for
at least 30 min. Mechanical allodynia of the
plantar surface of the hind paw was determined
by measuring the paw withdrawal threshold in
response to probing with von Frey monofila-
ments. The most sensitive area was first deter-
mined by poking various areas of the paw with
a von Frey hair. Testing for mechanical allodynia
was then conducted by gently poking the most
sensitive spot with the filament. Withdrawal
threshold was determined by increasing and
decreasing stimulus intensity between 0.2 and 12
g equivalents of force using a von Frey filament,
and estimated when the force produced a 50%
response rate after 10 applications to each hind
paw. To quantify cold allodynia, mice were
placed on a metal mesh floor under a trans-
parent plastic dome and brisk paw withdrawal
in response to acetone application was measured.
An acetone bubble was applied 5 times (once
every 5 min) to each paw. The frequency of paw
withdrawal was expressed as a percentage re-
sponse rate to the application of acetone 10 times
to each hind paw. To quantify heat hyperalgesia,
the latency of paw withdrawal to noxious heat
stimuli was measured. Each mouse was placed
on a wire mesh floor under which a light box
was located. A radiant heat stimulus was applied
by aiming a beam of light through a hole (10
mm) in the light box to the thigh or foot through
the wire mesh. The paw withdrawal latency was
defined as the time from the start of the light
beam to the lifting of the paw from the floor.
Fifteen seconds were allowed between stimula-
tions and 5 measurements were made on each
side of the hindlimb of each mouse on each day.
The 5 measurements were averaged and re-
corded as the paw withdrawal latency on a
given day. Behavioral assessments of mechanical
allodynia, cold allodynia, and heat hyperalgesia
were made of both the ipsilateral and contra-
lateral sides to the tumor.
Histology
Mice were sacrificed at regular intervals after
the injection of tumor cells. Tumor-bearing hind
paws were fixed in 4% zinc-buffered formalin in
0.1 M PBS at 4 overnight, decalcified in 10%
EDTA (pH 7.4) for 2 weeks, and embedded in
paraffin. Paraffin blocks were sectioned 7 m- μ
thick, stained with Hematoxylin and Eosin, and
examined under the light microscope.
Statistical analysis
Data are expressed as means ± SE. Differences
in pain behaviors following inoculation of HCa-1
cells or vehicle (control medium) were tested
using the Student's t-test at each time point.
Statistical significance was set at p < 0.05.Bae Hwan Lee, et al.
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RESULTS
Behavioral assessments
The response threshold of foot withdrawals to
repeated mechanical stimulation was plotted for
each group (the control group vs the cancer-
treated group) against time (Fig. 1). It should be
noted that mice showed a high response threshold
to stimulation of the paw before tumor inocu-
lation, and that vehicle treated mice maintained
high threshold responsiveness to mechanical
stimulation in all groups. The most vigorous
mechanical allodynia was developed in the
animals with a tumor in the hind paw (Fig. 1A).
In the figures, asterisks indicate significant dif-
ferences between HCa-1 inoculation and vehicle
groups. Mice with HCa-1 inoculation in the foot
showed remarkable mechanical allodynia from 7
days after inoculation (Fig. 1A). In addition,
unexpectedly, these mice showed mechanical al-
lodynia at 28 days after inoculation on the con-
tralateral side, indicating mirror image pain (Fig.
1B). In contrast, mice with HCa-1 inoculation in
the thigh did not show any remarkable mechani-
cal allodynia either on the ipsilateral or contra-
lateral side (Fig. 1C and 1D).
The frequencies of foot withdrawals to repeated
cold stimulation (with acetone bubble) were plot-
ted for each group against time (Fig. 2). The
animals with a tumor in the hind paw showed the
most vigorous cold allodynia (Fig. 2A). In the
figures, asterisks indicate significant differences
between HCa-1 inoculation and vehicle groups.
Mice with HCa-1 inoculation in the foot showed
remarkable cold allodynia from 7 days after
inoculation (Fig. 2A). In addition, these mice also
showed cold allodynia from 7 days after inocula-
Fig. 1. Development of mechanical allodynia after inoculation of hepatocarcinoma cells (HCa-1) into the thigh or the
dorsum of the foot in mice. A: Mechanical allodynia on the ipsilateral foot, B: Mechanical allodynia on the contralateral
foot, C: Mechanical allodynia on the ipsilateral thigh, D: Mechanical allodynia on the contralateral thigh. Response
thresholds to von Frey filaments with different bending forces were used as an index of mechanical allodynia. Data were
expressed as means ± SE. Abscissa was marked as Pre for pre-inoculation control and D for post-inoculation days.
Asterisks (*) indicate significant differences between HCa-1 and vehicle groups at each time point by Student's t-test (p
< 0.05).Animal Model of Cancer Pain
Yonsei Med J Vol. 46, No. 2, 2005
tion on the contralateral side, indicating mirror
image pain (Fig. 2B). In contrast, mice with HCa-1
inoculation in the thigh showed low levels of cold
allodynia both on the ipsilateral and contralateral
side (Fig. 2C and 2D).
The latencies of hind paw withdrawal to
noxious radiant heat stimulus were plotted for
each group against time (Fig. 3). As shown in the
figure, heat hyperalgesia was not observed in any
animals with a tumor in the foot or the thigh (Fig.
3A and C). In addition, these animals did not
show sensitivity to heat on the contralateral side
(Fig. 3B and D).
Histological examination
Bone invasion of cancer cells in the ipsilateral
hind paw was detected from 7 days and was
evident from 14 days after inoculation. Fig. 4
shows the histopathological examinations of
ipsilateral hind paw at 7 and 14 days after injec-
tion of HCa-1 cells. At day 7, bone invasion com-
menced and became obvious at day 14 with bone
destruction.
DISCUSSION
In the present study, behavioral signs of pain
gradually developed after the inoculation of
HCa-1 cells into the foot but not the thigh of mice.
Moreover, normally innocuous mechanical and
thermal stimuli applied to the receptive field
ipsilateral to the tumor produced a pain experi-
ence, so called mechanical allodynia and cold
allodynia, respectively. However, hyperalgesia
(painful stimuli applied to the receptive field
producing more increased pain) was not observed
in our study. In addition, signs of spontaneous
pain, such as lifting of the paw, were not observed
(data not shown).
We also observed increased sensitivity (mirror
image pain) on the contralateral side of the tumor.
It is well established that the threshold of the
Fig. 2. Development of cold allodynia after inoculation of hepatocarcinoma cells (HCa-1) into the thigh or the dorsum
of the foot in mice. A: Cold allodynia on the ipsilateral foot, B: Cold allodynia on the contralateral foot, C: Cold allodynia
on the ipsilateral thigh, D: Cold allodynia on the contralateral thigh. Response rates to acetone application were used as
an index of cold allodynia. Data were expressed as means ± SE. Abscissa was marked as Pre for pre-inoculation control
and D for post-inoculation days. Asterisks (*) indicate significant differences between HCa-1 and vehicle groups at each
time point by Student's t-test (p < 0.05).Bae Hwan Lee, et al.
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reflexive withdrawal response of the ipsilateral
paw to external stimuli decreases after various
kinds of injury to the unilateral hind limbs of rats.
This phenomenon indicates one of the typical
neuropathic pain behaviors known as hyperal-
gesia or allodynia. Similarly, the contralateral
hind paw can be sensitive to stimuli applied to the
same contralateral paw, a phenomenon termed
“mirror image pain” behavior.
Sometimes, painful neuropathic symptoms
spread to the side opposite the nerve injury in
humans.
9-12 For example, Livingston
10 and
Mitchell
11 reported about the later development of
neuropathic signs on the side contralateral to the
original painful injured side. Similar clinical
observations that painful neuropathic symptoms
may spread to the side opposite the nerve injury
have been reported.
9,12 The condition whereby the
signs and symptoms of a long-standing pain
syndrome are reflected in the contralateral ex-
tremity is called “mirror image pain”.
10
Mirror image pain has been reported in several
experimental animal models of neuropathic
pain
13-17 and different experimental paradigms in
the absence of lesions of the nervous system.
18,19
All these observations suggest that otherwise
insensitive body areas contralateral to an injured
side can become sensitive following unilateral
injury, and that originally painful states on one
side may manifest into secondary pain on the
other side known as “mirror image pain”. In the
present study, unexpectedly the mice with a
tumor developed mirror image pain.
Pain is the most frequently presented symptom
in cancer. The character of pain from cancer can
differ depending on the tissue or organ involved
and the tumor type.
20 For example, Wacnik et al.
21
observed hyperalgesia produced by implantation
of fibrosarcoma cells into the C3H/HeJ mouse
calcaneus bone but not by melanoma tumors. In
Fig. 3. Development of heat hyperalgesia after inoculation of hepatocarcinoma cells (HCa-1) into the thigh or the dorsum
of the foot in mice. A: Heat hyperalgesia on the ipsilateral foot, B: Heat hyperalgesia on the contralateral foot, C: Heat
hyperalgesia on the ipsilateral thigh, D: Heat hyperalgesia on the contralateral thigh. Response latency to radiant heat was
used as an index of heat hyperalgesia. Data were expressed as means ± SE. Abscissa was marked as Pre for pre-inoculation
control and D for post-inoculation days. Asterisks (*) indicate significant differences between HCa-1 and vehicle groups
at each time point by Student's t-test (p < 0.05).Animal Model of Cancer Pain
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the present study, we observed severe bone inva-
sion after the inoculation of HCa-1 cells. Patholo-
gical changes in the bone itself or surrounding
tissues may contribute to pain in chronic states of
cancer.
At present, the mechanisms of cancer pain
remain to be determined, at least in part, due to
a lack of animal models of cancer pain. Recently,
however, several animal models of cancer pain
were reported. Schwei et al.
5 have reported the
first animal model of bone cancer pain, Subse-
quently, other animal models of cancer pain have
been developed by implantation of tumor cells
within bone or overlying tissues adjacent to bones
in rats
6 and mice.
21,22-24 According to these animal
models of cancer pain, different models display
different behavioral signs of cancer pain. Our
model of cancer pain appears to show somewhat
different aspects of cancer pain compared to other
animal models of cancer pain.
The severity of cancer pain does not depend on
the size, location, or type of tumor. Thus, different
patients with the same type of cancer located in
the same peripheral tissue may experience dif-
ferent type and severity of cancer pain.
25 These
clinical evidences may explain behavioral dif-
ferences in animal models of cancer pain.
In order to try to elucidate the mechanisms of
cancer pain, Honore et al.
23 compared the neuro-
chemical changes in the spinal cord and sensory
neurons using three different murine pain models.
According to their study, substance P, calcitonin
gene-related peptide (CGRP), and protein kinase
Cγ were up-regulated in the spinal cord in the
inflammatory pain model and down-regulated in
the neuropathic pain model. In contrast, there
were no significant changes in either of these
neurotransmitters in the cancer pain model.
Galanin and neuropeptide Y were dramatically
up-regulated in dorsal root ganglion neurons in
Fig. 4. Morphological changes in the hind paw after inoculation of hepatocarcinoma cells. Gross photos (A) and
histopathological examinations (B, ×100, H & E staining) of ipsilateral hind paw, 7 and 14 days after injection of HCa-1
cells. At day 7, bone invasion commences and becomes obvious at day 14 with bone destruction, as indicated by arrows.
A B
Day 7
Day 14Bae Hwan Lee, et al.
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neuropathy, whereas no change in these neur-
opeptides was observed in the cancer pain model.
However, the up-regulation of glial fibrillary
acidic protein (GFAP) in the spinal cord was
observed in the cancer pain model. Similarly,
Medhurst et al.
6 observed significant enhancement
of GFAP staining in the corresponding segments
of the ipsilateral spinal cord, suggesting the
possible involvement of astrocytes. These results
indicate that cancer pain is not merely a form of
pain due to inflammation and/or neuropathy but
rather is a distinct pain state.
23
Even now, detailed mechanisms of cancer pain
still remain unclear. For example, the neural
circuits and putative transmitters related to cancer
pain have not been determined. Despite the lack
of information of detailed mechanisms, cancer
pain appears to reflect central changes involving
various morphological, physiological, and bioche-
mical processes. Thus, special efforts should be
oriented to reveal the mechanisms and modula-
tions of cancer pain using animal models of cancer
pain.
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